When should letrozole (2.5 mg) be taken?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Take Letrozole 2.5 mg

Letrozole 2.5 mg should be taken once daily, at the same time each day, without regard to meals 1.

Timing Based on Clinical Indication

For Breast Cancer (Adjuvant/Extended Adjuvant Treatment)

Take letrozole continuously, once daily, starting after completion of prior endocrine therapy:

  • Standard adjuvant treatment: Begin after diagnosis in postmenopausal women with hormone receptor-positive early breast cancer. Continue for up to 5 years or until disease relapse 2, 1.

  • Extended adjuvant treatment: Begin after completing 5 years of tamoxifen therapy. The FDA-approved regimen involves continuous daily dosing, with treatment duration based on the MA.17R and NSABP B-42 trials showing benefit with 5 additional years of therapy 2, 1.

The evidence from multiple large trials (MA.17R with 1,918 patients, NSABP B-42 with 3,923 patients) consistently demonstrates that letrozole 2.5 mg daily taken continuously is the standard approach 2. The SOLE trial compared continuous versus intermittent dosing (9 months on, 3 months off) and found no significant difference in disease-free survival, though continuous dosing remains the standard 2.

Important Considerations for Breast Cancer Treatment:

  • No meal restrictions: Take with or without food 1
  • Consistency matters: Take at approximately the same time each day to maintain stable drug levels
  • Duration: Median treatment duration in trials was 60 months (5 years) for extended adjuvant therapy 1
  • Monitoring: Given increased risk of bone fractures (14% vs 9% with placebo, p=0.001) and new osteoporosis (11% vs 6%, p<0.001), bone mineral density monitoring is recommended 2

For Hepatic Impairment:

Patients with cirrhosis and severe hepatic dysfunction should take 2.5 mg every other day (50% dose reduction) 1.

Key Safety Points

Common adverse effects occurring in >20% of patients include hot flashes (38%), arthralgia (53%), fatigue (36%), and musculoskeletal pain 2. These do not typically require dose modification but should be monitored.

Contraindications: Do not use in pregnancy or if hypersensitive to letrozole 1.

The evidence strongly supports once-daily continuous dosing as the optimal regimen, with the timing of administration flexible based on patient preference, but consistency in daily timing is recommended for optimal therapeutic effect.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.